Living

FDA launches study of abortion pill safety, WSJ reports

By Reuters Reuters
FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo
FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Andrew Kelly Reuters

The FDA has launched a safety study of the abortion pill, also known as mifepristone, a step that could pave the way for the Trump administration to restrict how it is distributed and used, the Wall Street Journal reported on Thursday.

The FDA study, using existing drug-safety systems, is expected to take six months and aims to withstand legal criticism, the report said, citing administration officials.

Reuters could not immediately verify the report.

(Reporting by Mrinmay Dey in Mexico City; Editing by Himani Sarkar)

Copyright Reuters or USA Today Network via Reuters Connect

This story was originally published June 4, 2026 at 6:10 PM.

Get unlimited digital access
#ReadLocal

Try 1 month for $1

CLAIM OFFER